{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:50:24Z","timestamp":1777441824375,"version":"3.51.4"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["386569-2010"],"award-info":[{"award-number":["386569-2010"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>Erythropoietin (<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>) is used to treat anaemia associated with chronic kidney disease (<jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>). Hypoxia is associated with anaemia and is known to cause a decrease in cytochrome<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>450 (<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>450) expression. As<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>production is regulated by hypoxia, we investigated the role of<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>on<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>450 expression and function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>Male<jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>istar rats were subjected to a 0.7% adenine diet for 4 weeks to induce<jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>. The diet continued for an additional 2 weeks while rats received<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>by i.p. injection every other day. Following euthanasia, hepatic<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>450<jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>and protein expression were determined. Hepatic enzyme activity of selected<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>450s was determined and chromatin immunoprecipitation was used to characterize binding of nuclear receptors involved in the transcriptional regulation of<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>2<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>and<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>3<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>administration decreased hepatic<jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>and protein expression of<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>3<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>2 (<jats:styled-content style=\"fixed-case\"><jats:italic>P<\/jats:italic><\/jats:styled-content>&lt; 0.05), but not<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>2<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>11. Similarly,<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>administration decreased<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>3<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>2 protein expression by 81% (<jats:styled-content style=\"fixed-case\"><jats:italic>P<\/jats:italic><\/jats:styled-content>&lt; 0.001). A 32% decrease (<jats:styled-content style=\"fixed-case\"><jats:italic>P<\/jats:italic><\/jats:styled-content>&lt; 0.05) in hepatic<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>3<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>enzymatic activity (<jats:styled-content style=\"fixed-case\"><jats:italic>V<\/jats:italic><\/jats:styled-content><jats:sub>max<\/jats:sub>) was observed for the formation of 6<jats:styled-content style=\"fixed-case\">\u03b2OH<\/jats:styled-content>\u2010testosterone in the<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>\u2010treated group. Decreases in<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content>pol<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>recruitment (<jats:styled-content style=\"fixed-case\"><jats:italic>P<\/jats:italic><\/jats:styled-content>&lt; 0.01), hepatocyte nuclear factor 4<jats:styled-content style=\"fixed-case\">\u03b1<\/jats:styled-content>binding (<jats:styled-content style=\"fixed-case\"><jats:italic>P<\/jats:italic><\/jats:styled-content>&lt; 0.05) and pregnane<jats:styled-content style=\"fixed-case\">X<\/jats:styled-content>receptor binding (<jats:styled-content style=\"fixed-case\"><jats:italic>P<\/jats:italic><\/jats:styled-content>&lt; 0.01) to the promoter region of<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>3<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>were also observed in<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>\u2010treated rats.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p>Our data show that<jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content>decreases the expression and function of<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>3<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>, but not<jats:styled-content style=\"fixed-case\">CYP<\/jats:styled-content>2<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>in rat liver.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.12932","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T03:37:25Z","timestamp":1410752245000},"page":"201-213","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of erythropoietin on hepatic cytochrome<scp>P<\/scp>450 expression and function in an adenine\u2010fed rat model of chronic kidney disease"],"prefix":"10.1111","volume":"172","author":[{"given":"D A","family":"Feere","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology Western University London ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J","family":"Velenosi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology Western University London ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B L","family":"Urquhart","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology Western University London ON Canada"},{"name":"Department of Medicine Schulich School of Medicine and Dentistry Western University London ON Canada"},{"name":"Lawson Health Research Institute London ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12451"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12448"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.6.7.2731"},{"key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-3565(25)28609-8","article-title":"Effects of iron, riboflavin and iodide deficiencies on hepatic drug\u2010metabolizing enzyme systems","volume":"174","author":"Catz CS","year":"1970","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250701245250"},{"key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/jn\/119.1.40","article-title":"Effects of different degrees of iron deficiency on cytochrome P450 complex and pentose phosphate pathway dehydrogenases in the rat","volume":"119","author":"Dhur A","year":"1989","journal-title":"J Nutr"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2013.05.006"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016440.52271.F7"},{"key":"e_1_2_10_10_1","unstructured":"Food and Drug Administration (FDA)(2010).Pharmacokinetics in patients with impaired renal function \u2013 study design data analysis and impact on dosing and labeling."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704933"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V40.5.671.671"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb07192.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704951"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202739200"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-352-3_4"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00025a008"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1059796"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.3.1910"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01815.x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702795"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113363"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V122326"},{"key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0090-9556(24)15079-9","article-title":"Decreased in vivo metabolism of drugs in chronic renal failure","volume":"28","author":"Leblond FA","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.07.010"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.157180"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.876839"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh280"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23876"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.560177"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajkd.2003.07.019"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009010082"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)82244-3"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.284596"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81167-8"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1143"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-106195"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425250903012360"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2010-0395"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.217"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb03973.x"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2007.00844.x"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm815"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.931371"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.045245"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.9.4304"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.18.6310"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1851"},{"key":"e_1_2_10_52_1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0026-895X(25)14161-8","article-title":"Demonstration in multiple species of inducible hepatic cytochromes P\u2010450 and their mRNAs related to the glucocorticoid\u2010inducible cytochrome P\u2010450 of the rat","volume":"28","author":"Wrighton SA","year":"1985","journal-title":"Mol Pharmacol"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02353474"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"e_1_2_10_55_1","first-page":"215","article-title":"The comparison of the normal blood biochemical values of Wistar rats with different age and sex","volume":"4","author":"Zhang ZP","year":"2004","journal-title":"Asian J Drug Metab Pharmacokinet"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12932","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:33:20Z","timestamp":1746376400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1111\/bph.12932"],"URL":"https:\/\/doi.org\/10.1111\/bph.12932","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,24]]},"assertion":[{"value":"2014-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}